KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Account Payables (2020 - 2025)

Clover Health Investments' Change in Account Payables history spans 6 years, with the latest figure at -$18.3 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 9.78% year-over-year to -$18.3 million; the TTM value through Dec 2025 reached -$22.6 million, down 17.96%, while the annual FY2025 figure was -$22.6 million, 17.96% down from the prior year.
  • Change in Account Payables reached -$18.3 million in Q4 2025 per CLOV's latest filing, down from $38.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $68.1 million in Q2 2023 to a low of -$94.8 million in Q4 2022.
  • Average Change in Account Payables over 5 years is $441050.0, with a median of $5.9 million recorded in 2021.
  • Peak YoY movement for Change in Account Payables: skyrocketed 2156.25% in 2021, then tumbled 921.69% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $11.5 million in 2021, then crashed by 921.69% to -$94.8 million in 2022, then skyrocketed by 93.22% to -$6.4 million in 2023, then crashed by 215.55% to -$20.3 million in 2024, then rose by 9.78% to -$18.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Change in Account Payables are -$18.3 million (Q4 2025), $38.9 million (Q3 2025), and $273000.0 (Q2 2025).